The Strange Case of the Botulinum Neurotoxin: Using Chemistry and Biology to Modulate the Most Deadly Poison
- 15 October 2008
- journal article
- review article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 47 (44) , 8360-8379
Abstract
In the classic novella “The Strange Case of Dr. Jekyll and Mr. Hyde”, Robert Louis Stevenson paints a stark picture of the duality of good and evil within a single man. Botulinum neurotoxin (BoNT), the most potent known toxin, possesses an analogous dichotomous nature: It shows a pronounced morbidity and mortality, but it is used with great effect in much lower doses in a wide range of clinical scenarios. Recently, tremendous strides have been made in the basic understanding of the structure and function of BoNT, which have translated into widespread efforts towards the discovery of biomacromolecules and small molecules that specifically modulate BoNT activity. Particular emphasis has been placed on the identification of inhibitors that can counteract BoNT exposure in the event of a bioterrorist attack. This Review summarizes the current advances in the development of therapeutics, including vaccines, peptides, and small‐molecule inhibitors, for the prevention and treatment of botulism.Keywords
This publication has 150 references indexed in Scilit:
- Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccineVaccine, 2007
- Single molecule detection of intermediates during botulinum neurotoxin translocation across membranesProceedings of the National Academy of Sciences, 2007
- An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonistsProceedings of the National Academy of Sciences, 2007
- Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor conceptProceedings of the National Academy of Sciences, 2007
- Synthesis, Characterization and Development of a High-Throughput Methodology for the Discovery of Botulinum Neurotoxin A InhibitorsJournal of Combinatorial Chemistry, 2006
- Identification of a Potent Botulinum Neurotoxin A Protease Inhibitor Using in Situ Lead Identification ChemistryOrganic Letters, 2006
- Peptide inhibitors of botulinum neurotoxin by mRNA displayBiochemical and Biophysical Research Communications, 2005
- SNARE motif and neurotoxinsNature, 1994
- SNAP receptors implicated in vesicle targeting and fusionNature, 1993
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986